Literature DB >> 18706951

DNA sequence analysis of varicella-zoster virus gene 62 from subclinical infections in healthy children immunized with the Oka varicella vaccine.

Yasuyuki Gomi1, Takao Ozaki, Naoko Nishimura, Atsushi Narita, Michio Suzuki, Jaekun Ahn, Naoko Watanabe, Norio Koyama, Hajime Ushida, Naoko Yasuda, Kazumasa Nakane, Keiji Funahashi, Isao Fuke, Akihisa Takamizawa, Toyokazu Ishikawa, Koichi Yamanishi, Michiaki Takahashi.   

Abstract

A live attenuated varicella vaccine, the Oka vaccine strain (vOka), is routinely administered to children in Japan and other countries, including the United States. vOka consists of a mixture of genotypically distinct variants, but little is known about the growth potential of each variants in vivo. We isolated varicella-zoster virus (VZV) DNA sequences from the peripheral blood mononuclear cells (PBMCs) of asymptomatic healthy children immunized with the Oka varicella vaccine. VZV gene 62 DNA fragments were detected in 5 of 166 (3.0%) PBMC samples by nested PCR within 5 weeks of the vaccination. Sequence analysis of VZV DNA from these five PBMC samples indicated that multiple viral clones in the vaccine could infect vaccinees and replicate in vivo. We also provide evidence that a nonsynonymous substitution at position 105356 may affect viral replication in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18706951     DOI: 10.1016/j.vaccine.2008.07.069

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

1.  Molecular analysis of varicella vaccines and varicella-zoster virus from vaccine-related skin lesions.

Authors:  Sonja Thiele; Aljona Borschewski; Judit Küchler; Marc Bieberbach; Sebastian Voigt; Bernhard Ehlers
Journal:  Clin Vaccine Immunol       Date:  2011-05-11

2.  Variability of immediate-early gene 62 in german varicella-zoster virus wild-type strains.

Authors:  A Sauerbrei; K Bohn; R Zell; P Wutzler
Journal:  J Clin Microbiol       Date:  2009-08-26       Impact factor: 5.948

3.  Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive Therapies.

Authors:  Kim A Papp; Boulos Haraoui; Deepali Kumar; John K Marshall; Robert Bissonnette; Alain Bitton; Brian Bressler; Melinda Gooderham; Vincent Ho; Shahin Jamal; Janet E Pope; A Hillary Steinhart; Donald C Vinh; John Wade
Journal:  J Cutan Med Surg       Date:  2018-11-21       Impact factor: 2.092

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.